Alert icon

To align with industry best practices for security and data integrity, Project Data Sphere is requiring users to upgrade their browsers to one that supports encryption protocol TLS 1.2 by December 15, 2017. On that date, Project Data Sphere will disable support of browsers that permit SSL 3.0/TLS 1.0. To prevent any disruption to your access to Project Data Sphere, you must take action.
This browser was not recognized and may not be compatible with TLS 1.2 or higher. Please check with the browser's developer to confirm.
To view information about this, please visit the FAQ. If you have any further questions, please contact us.

Back to the List
Type(s) of Cancer
Leukemia/Lymphoma
Study Phase
Phase 3
Study Completion Date
2018-10-24
NCT02048813Uploaded 03-31-2023
Access via NCI by Request
PDS UID: nci-data-513
A Randomized Phase III Study of Ibrutinib (PCI-32765)-Based Therapy vs Standard Fludarabine, Cyclophosphamide, and Rituximab (FCR) Chemoimmunotherapy in Untreated Younger Patients With Chronic Lymphocytic Leukemia (CLL)
Files: NCT02048813-D1
Data DictionaryNCT02048813-D1-Data-Dictionary_2.pdf
DATANCT02048813-D1-Dataset_3.txt
OTHERREADME.pdf
Files: NCT02048813-D2
Data DictionaryNCT02048813-D2-Data-Dictionary_2.pdf
DATANCT02048813-D2-Dataset_2.txt
OTHERREADME.pdf
Files: NCT02048813-D3
Data DictionaryNCT02048813-D3-Data-Dictionary_2.pdf
DATANCT02048813-D3-Dataset_2.txt
OTHERREADME.pdf